Pyridostigmine Bromide (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Pyridostigmine Bromide drug offered from KAISER FOUNDATION HOSPITALS. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Pyridostigmine Bromide
SUBSTANCE NAME: PYRIDOSTIGMINE BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-08-02
END MARKETING DATE: 0000-00-00


Pyridostigmine Bromide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPyridostigmine Bromide from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/1)
START MARKETING DATE: 2010-08-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0070_96e3b125-6174-429d-8140-421afe0427f0
PRODUCT NDC: 0179-0070
APPLICATION NUMBER: ANDA040457

Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALVOGEN INC.Pyridostigmine Bromide
American Health PackagingPyridostigmine Bromide
Bryant Ranch Prepackpyridostigmine bromide
Cadila Healthcare Limitedpyridostigmine bromide
Impax GenericsPyridostigmine Bromide
KAISER FOUNDATION HOSPITALSPyridostigmine Bromide
Major Pharmaceuticalspyridostigmine bromide
Oceanside Pharmaceuticalspyridostigmine bromide
Sandoz IncRegonol
Valeant Pharmaceuticals North America LLCMestinon
Zydus Pharmaceuticals (USA) Inc.pyridostigmine bromide